Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F-R Ferrand

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
La Revue De Medecine Interne|June 18, 2014
[Therapeutic targeted approaches on androgen receptors in prostate cancer]F-R Ferrand, M Pavic
La Revue De Medecine Interne|November 21, 2008
[A nodular splenomegaly]F-R Ferrand, S Guymar, H Daligand, et al.
Case Reports in Medicine|June 2, 2011
Granulocytic sarcoma in a nonleukemic patient: place of radiotherapy and systemic therapiesC Chargari, J Jacob, O Bauduceau, et al.
Revue De Pneumologie Clinique|October 12, 2010
[Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)]J Margery, F Rivière, D Planchard, et al.
La Revue De Medecine Interne|July 23, 2013
[Neuroendocrine carcinoma of the digestive tract: a literature review]J Jacob, C Chargari, C Helissey, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|December 1, 2023
Systemic therapies for salivary gland carcinoma (excluding adenoid cystic carcinoma): REFCOR recommendations by the formal consensus methodV Sarradin, L Digue, S Vergez, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|December 7, 2023
Systemic therapies for salivary gland cancer: Adenoid cystic carcinoma. REFCOR recommendations by the formal consensus methodF-R Ferrand, C Even, E Chabrillac, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|November 29, 2023
Radiotherapy for salivary gland cancer: REFCOR recommendations by the formal consensus methodJ Thariat, F-R Ferrand, N Fakhry, et al.
Critical Reviews in Oncology/Hematology|June 18, 2011
Disseminated and circulating tumor cells in gastrointestinal oncologyF C Bidard, F R Ferrand, F Huguet, et al.
Oral Oncology|June 11, 2013
Multimodal treatment and long-term outcome of patients with esthesioneuroblastomaA Modesto, P Blanchard, Y G Tao, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
La Revue De Medecine Interne|June 18, 2014
[Therapeutic targeted approaches on androgen receptors in prostate cancer]F-R Ferrand, M Pavic
La Revue De Medecine Interne|November 21, 2008
[A nodular splenomegaly]F-R Ferrand, S Guymar, H Daligand, et al.
Case Reports in Medicine|June 2, 2011
Granulocytic sarcoma in a nonleukemic patient: place of radiotherapy and systemic therapiesC Chargari, J Jacob, O Bauduceau, et al.
Revue De Pneumologie Clinique|October 12, 2010
[Second-line therapy in patients with malignant pleural mesothelioma. A French retrospective study (2005-2006)]J Margery, F Rivière, D Planchard, et al.
La Revue De Medecine Interne|July 23, 2013
[Neuroendocrine carcinoma of the digestive tract: a literature review]J Jacob, C Chargari, C Helissey, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|December 1, 2023
Systemic therapies for salivary gland carcinoma (excluding adenoid cystic carcinoma): REFCOR recommendations by the formal consensus methodV Sarradin, L Digue, S Vergez, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|December 7, 2023
Systemic therapies for salivary gland cancer: Adenoid cystic carcinoma. REFCOR recommendations by the formal consensus methodF-R Ferrand, C Even, E Chabrillac, et al.
European Annals of Otorhinolaryngology, Head and Neck Diseases|November 29, 2023
Radiotherapy for salivary gland cancer: REFCOR recommendations by the formal consensus methodJ Thariat, F-R Ferrand, N Fakhry, et al.
Critical Reviews in Oncology/Hematology|June 18, 2011
Disseminated and circulating tumor cells in gastrointestinal oncologyF C Bidard, F R Ferrand, F Huguet, et al.
Oral Oncology|June 11, 2013
Multimodal treatment and long-term outcome of patients with esthesioneuroblastomaA Modesto, P Blanchard, Y G Tao, et al.
Pageof 2